Celldex Therapeutics, Inc

CLDXNASDAQ

Healthcare · In Vitro & In Vivo Diagnostic Substances

Market cap

$2.48B

Employees

198

Exchange

NASDAQ

Headquarters

HAMPTON, NJ

About Celldex Therapeutics, Inc

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Industry

In Vitro & In Vivo Diagnostic Substances

Sector

Healthcare

Country

US

Website

www.celldex.com